The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...

The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...

A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, ...

Adults with obesity or who were overweight lost 15% of their body weight on average after taking Wegovy for one year ... say more long-term data is needed before committing patients to this ...

Since we first wrote this story in 2015, the Men's Health ... And even after multiple washes, the softness doesn't diminish—a true sign of premium quality. Before you raise an eyebrow, we ...

A strong second half from the Cougars helped them escape with a four-point win, moving them to an absurd 13-1 in Big 12 play and setting them up to hop into the Top 5 after Tennessee split its ...

When it comes to men's singles, only a handful of names have ... Jannik Sinner holds firm in the number one spot after claiming a second-straight Australian Open title. Tommy Paul has recently ...

A Pakistani journalist shared a video on social media wherein a fan could be seen urging the Men in Green to not hug Virat Kohli or ... Three days later, they will take on Pakistan before locking ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared ...

Hims & Hers Health shares swooned after the Food & Drug Administration said the active ingredient in Ozempic and Wegovy is no longer in short supply. The company makes compounded versions of ...